文献速递创伤与烧伤重症综合管理与镇静镇痛

创伤后升高的游离血红蛋白:一种新型早期生物标志物

Elevated cell-free hemoglobin: A novel early biomarker following traumatic injury.
PubMed 文献 · J Trauma Acute Care Surg · 2024-12-26
一句话结论严重创伤患者到达急诊时血浆游离血红蛋白即升高(中位10.9 μM),最高组(约25 μM)住院更长、并发症更多,作者认为早期纠正溶血可能获益。

该前瞻性研究在2021至2023年于一家一级创伤中心纳入119例最高级别启动的成年创伤患者,到达时(输血前)及入住后6、12、24小时采血检测游离血红蛋白、结合珠蛋白、血红素和血红素结合蛋白。患者以男性为主(101:18),中位年龄48岁,损伤严重度评分中位22,28天死亡率11%。游离血红蛋白在急诊到达时即升高(中位10.9 μM),随后下降但仍高于正常水平(>5 vs 约0.2 μM);存在一组到达时游离血红蛋白高2至3倍(中位25 μM)的患者,其住院时间更长、并发症更频繁。作者认为游离血红蛋白在创伤后很早期即升高并可能影响结局,早期纠正溶血可能带来获益,但需进一步研究。

要点

  • 严重创伤患者到达急诊时(输血前)血浆游离血红蛋白即升高,中位10.9 μM(IQR 6.8-17.6)。
  • 监测期间游离血红蛋白虽下降但仍高于正常水平(>5 vs 约0.2 μM),初始下降归因于结合珠蛋白结合与清除。
  • 存在到达时游离血红蛋白高2至3倍(中位25 μM)的亚组,该组住院时间更长、并发症更频繁。
  • 研究人群为最高级别启动的成年创伤患者,中位损伤严重度评分22,28天死亡率11%。
  • 作者认为早期纠正溶血可能带来获益,但需进一步研究。

适用人群与场景

  • 2021至2023年在一家一级创伤中心前瞻性纳入的成人最高级别启动创伤患者,以钝性暴力伤为主。

研究设计与关键结果

  • 前瞻性研究,纳入119例患者,男性101例、女性18例,中位年龄48岁(IQR 31-64岁),中位损伤严重度评分22(IQR 11-29),28天死亡率11%。
  • 到达急诊时(输血前)游离血红蛋白中位10.9 μM(IQR 6.8-17.6),随后下降但监测期间仍高于正常水平(>5 vs 约0.2 μM)。
  • 初始游离血红蛋白下降归因于结合珠蛋白结合与清除。
  • 存在到达时游离血红蛋白高2至3倍(中位25 μM)的亚组,该组住院时间更长、并发症更频繁。

证据类型、等级与局限

  • 预后/流行病学研究,证据等级III级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,早期纠正溶血可能带来获益,但需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Cell-free hemoglobin (CFH) and free heme are potent mediators of endotheliopathy and organ injury in sepsis, but their roles in other hemolytic pathologies are not well-defined. A prime example is trauma where early hemolysis may initiate damage and predict outcome. Here, we investigated the presence of plasma CFH, heme, and their major scavengers after traumatic injury.

METHODS: Adult patients who presented as highest-level activations were prospectively enrolled at a level 1 trauma center between 2021 and 2023. Venous blood was collected upon arrival (pretransfusion) and 6, 12, and 24 hours after admittance for quantification of CFH, haptoglobin, heme, and hemopexin.

RESULTS: We studied 119 mostly male subjects (101:18) with a median age of 48 years (interquartile range [IQR], 31-64 years) and an Injury Severity Score of 22 (IQR, 11-29); the majority had suffered blunt force trauma. The 28-day mortality rate was 11%. Cell-free hemoglobin was high upon emergency department arrival (10.9 μM; IQR, 6.8-17.6) and then declined but remained elevated compared with normative levels during the monitoring period (>5 vs. ~0.2 μM). The initial drop in CFH was attributed to haptoglobin binding and clearance. Notably, there was a subgroup of patients with two- to threefold higher levels of CFH on emergency department arrival (median, 25 μM). Patients with these highest CFH levels had longer hospital stays and more frequent complications.

CONCLUSION: Cell-free hemoglobin is elevated in trauma patients very early after injury and may impact outcome. While further work is needed, early correction of hemolysis could provide benefit.

LEVEL OF EVIDENCE: Prognostic/Epidemiological Study; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Ross JT, Robles AJ, Barnes A, et al. Elevated cell-free hemoglobin: A novel early biomarker following traumatic injury. J Trauma Acute Care Surg. 2024. PMID: 39722178. doi:10.1097/TA.0000000000004543

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。